Implant for Walking After Incomplete SCI

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorLouis Stokes VA Medical Center

About this trial

This is a device study that will evaluate the effect of an implanted stimulator on improving walking in people with incomplete spinal cord injury. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller development, and evaluation - this phase includes implanting the device and setting the individual up for system use, creating controllers for walking, and evaluating the effect of the device over a couple years.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Between the ages of 18-75

Non-ventilator dependent paralysis resulting from injuries such as: cervical/thoracic spinal cord injuries affecting the trunk and/or lower limbs

Impairment classification of AIS B, C, or D (preservation of sensation and/or some motor function) with weakness in trunk and/or lower extremity muscles

Unable to walk faster than 0.8m/s during a 10m walk test

Disqualifiers

Significant fracture risk or history of spontaneous fractures

History of heterotopic ossification at the hip, knee, or ankle

Non-English speaking

Insufficient upper extremity function to use an assistive device (e.g. walker or cane)

Trial design

Design model

Single group

Treatments tested in this trial

  • NNP-LE

    Device

    Networked NeuroProsthesis - Lower Extremity Configuration (NNP-LE) measuring physiologic command signals and delivering neural stimulation to intramuscular and nerve cuff electrodes for trunk and leg muscle assistance.

Treatment groups

5 Participants
are divided into 1 treatment group
Group A: Implantation, controller development and evaluationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Difference in maximum walking distance

The maximum walking distance is a measure of how far the participant can walk within a single bout over an unconstrained period of time. The measure is used to assess whether endurance and walking capacity improve. The difference between walking with and without the system turned on determines if the system improves walking capacity. Users serve as their own concurrent controls.

Time frame
Immediately after the participant is fully trained to use their implanted system

Secondary outcomes

1

Difference in spinal cord injury - functional ambulation inventory (SCI-FAI)

The SCI-FAI is an observational gait assessment that assesses three areas of walking: gait parameters, assistive device use, and walking mobility. The difference between walking with and without the system turned on determines if the system improves walking ability. Users serve as their own concurrent controls with and without device assistance.

Time frame
Immediately after the participant is fully trained to use their implanted system
2

Difference in Home and community mobility

A body worn step counter measures the number of steps taken daily over the course of about a month prior to implantation and then after implantation and system use. The difference between walking before and after having the system identifies if people walk more once they have the system. Users serve as their own longitudinal controls.

Time frame
Baseline and Immediately after the participant is fully trained to use their implanted system

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Louis Stokes VA Medical Center

Lead sponsor

MetroHealth Medical Center

Collaborator

CDMRP

Collaborator